These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8398831

  • 1. Reduced coagulation activation following infusion of a highly purified factor IX concentrate compared to a prothrombin complex concentrate.
    Hampton KK, Preston FE, Lowe GD, Walker ID, Sampson B.
    Br J Haematol; 1993 Jun; 84(2):279-84. PubMed ID: 8398831
    [Abstract] [Full Text] [Related]

  • 2. Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate.
    Mannucci PM, Bauer KA, Gringeri A, Barzegar S, Bottasso B, Simoni L, Rosenberg RD.
    Blood; 1990 Dec 15; 76(12):2540-5. PubMed ID: 2265248
    [Abstract] [Full Text] [Related]

  • 3. No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrate.
    Mannucci PM, Bauer KA, Gringeri A, Barzegar S, Santagostino E, Tradati FC, Rosenberg RD.
    Br J Haematol; 1991 Dec 15; 79(4):606-11. PubMed ID: 1772782
    [Abstract] [Full Text] [Related]

  • 4. A cross-over pharmacokinetic and thrombogenicity study of a prothrombin complex concentrate and a purified factor IX concentrate.
    Thomas DP, Hampton KK, Dasani H, Lee CA, Giangrande PL, Harman C, Lee ML, Preston FE.
    Br J Haematol; 1994 Aug 15; 87(4):782-8. PubMed ID: 7986719
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics, thrombogenicity and safety of a double viral inactivated factor IX concentrate compared with a prothrombin complex concentrate.
    Ruiz-Sáez A, Hong A, Arguello A, Echenagucia M, Boadas A, Fabbrizzi F, Minichilli F, Bosch NB.
    Haemophilia; 2005 Nov 15; 11(6):583-8. PubMed ID: 16236107
    [Abstract] [Full Text] [Related]

  • 6. A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate.
    Goudemand J, Peynet J, Chambost H, Négrier C, Briquel ME, Claeyssens S, Derlon-Borel A, Guérois C, Caron C, Scherrmann JM, Debray M, Bridey F.
    Thromb Haemost; 1998 Dec 15; 80(6):919-24. PubMed ID: 9869161
    [Abstract] [Full Text] [Related]

  • 7. Comparison of high purity factor IX concentrates and a prothrombin complex concentrate in a canine model of thrombogenicity.
    MacGregor IR, Ferguson JM, McLaughlin LF, Burnouf T, Prowse CV.
    Thromb Haemost; 1991 Nov 01; 66(5):609-13. PubMed ID: 1803625
    [Abstract] [Full Text] [Related]

  • 8. High purity factor IX and prothrombin complex concentrate (PCC): pharmacokinetics and evidence that factor IXa is the thrombogenic trigger in PCC.
    Philippou H, Adami A, Lane DA, MacGregor IR, Tuddenham EG, Lowe GD, Rumley A, Ludlam CA.
    Thromb Haemost; 1996 Jul 01; 76(1):23-8. PubMed ID: 8819246
    [Abstract] [Full Text] [Related]

  • 9. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T, Straub PW, Haeberli A.
    Thromb Haemost; 1994 Jan 01; 71(1):49-53. PubMed ID: 8165646
    [Abstract] [Full Text] [Related]

  • 10. Heparin supplement counteracts the prohemostatic effect of prothrombin complex concentrate and factor IX concentrate: An in vitro evaluation.
    Brinkman HJ, Patiwael S, Tripathi S, Meijers JC.
    Thromb Res; 2016 Mar 01; 139():102-10. PubMed ID: 26916304
    [Abstract] [Full Text] [Related]

  • 11. Fibrinopeptide A, prothrombin fragment 1 + 2, thrombin-antithrombin complex and D dimer before and after injection of a nonionic contrast medium (iohexol).
    Sorano GG, Paoletti P, Casciu G, Mameli G, Marongiu F.
    Haemostasis; 1997 Mar 01; 27(3):125-30. PubMed ID: 9306129
    [Abstract] [Full Text] [Related]

  • 12. Markers of in vivo activation of coagulation. Interrelationships change with intensity of oral anticoagulation.
    Solymoss S, Bovill EG.
    Am J Clin Pathol; 1996 Mar 01; 105(3):293-7. PubMed ID: 8602609
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of coagulation equilibrium at baseline and during factor VIII and factor IX replacement in haemophiliacs.
    Négrier C, Menart C, Attali O, Petit PY, Lienhart A, Dechavanne M, Ingerslev J.
    Blood Coagul Fibrinolysis; 1998 Mar 01; 9 Suppl 1():S135-41. PubMed ID: 9819045
    [Abstract] [Full Text] [Related]

  • 14. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
    Kario K, Matsuo T, Kodama K, Matsuo M.
    Thromb Res; 1992 Jun 01; 66(5):509-15. PubMed ID: 1523607
    [Abstract] [Full Text] [Related]

  • 15. In vivo coagulation activation following infusion of highly purified factor XI concentrate.
    Richards EM, Makris MM, Cooper P, Preston FE.
    Br J Haematol; 1997 Feb 01; 96(2):293-7. PubMed ID: 9029015
    [Abstract] [Full Text] [Related]

  • 16. Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentrates.
    Kim HC, McMillan CW, White GC, Bergman GE, Horton MW, Saidi P.
    Blood; 1992 Feb 01; 79(3):568-75. PubMed ID: 1531035
    [Abstract] [Full Text] [Related]

  • 17. Properties of factor IX concentrates.
    Berntorp E.
    Acta Haematol; 1995 Feb 01; 94 Suppl 1():8-11. PubMed ID: 7571997
    [Abstract] [Full Text] [Related]

  • 18. Markers of coagulation and fibrinolysis in portal blood from patients with and without gastric malignancy.
    Rahr HB, Sørensen JV, Larsen JF, Jensen FS, Bredahl C.
    Scand J Gastroenterol; 1994 Jun 01; 29(6):516-21. PubMed ID: 8079109
    [Abstract] [Full Text] [Related]

  • 19. Soluble, thrombin-related material in arterial thrombi and plasma studied during catheter-directed intra-arterial thrombolysis.
    Sandbaek G, Bjørnsen S, Brosstad F.
    Blood Coagul Fibrinolysis; 1999 Mar 01; 10(2):87-91. PubMed ID: 10192657
    [Abstract] [Full Text] [Related]

  • 20. Factor IX from prothrombin complex concentrate augments low dose tissue factor-triggered thrombin generation in vitro.
    Hasan S, Abuelkasem E, Williams B, Henderson R, Mazzeffi MA, Tanaka KA.
    Br J Anaesth; 2018 Oct 01; 121(4):936-943. PubMed ID: 30236256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.